Inhalation Sciences Sweden AB Employee Directory
Biotechnology ResearchStockholm, Sweden11-50 Employees
Inhalation Sciences Sweden AB is a Swedish contract research organization focused on inhaled drug development for INDs, generics, and biologics. It supports data-driven decision making early in development to mitigate risk, shorten timelines, and reduce costs. Based in Stockholm, Sweden, the company combines scientific leadership from its founder and CSO, Per Gerde, an associate professor of inhalation toxicology at Karolinska Institute, with a multidisciplinary team experienced in inhalation research. The firm's PreciseInhale platform enables precise aerosol dosing and pharmacokinetic data that better align with in-human results, contributing to greater clinical predictability and reduced use of API and animal testing. In January 2024, Inhalation Sciences Sweden AB announced a partnership with Actarmo Medical GmbH to offer inhalation development services from preclinical stages through formulation, device development, and clinical trial supplies.